Researchers discover that JAM-A protein keeps blood clots in check
those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.
May 3, 2012
0
0
those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.
May 3, 2012
0
0
Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of ...
Mar 26, 2012
0
0
Blood clots occur so rarely in children undergoing spine operations that most patients require nothing more than vigilant monitoring after surgery and should be spared risky and costly anti-clotting medications, according ...
Jul 15, 2014
0
0
(HealthDay)—Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP).
Feb 7, 2019
0
3
Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are more likely to have blood clots form on the stent and suffer a possible heart attack; conversely, patients with higher ...
Oct 25, 2012
0
0
Earlier this week, the BBC reported that one third of COVID-19 patients developed dangerous blood clots. While current treatments are mainly focusing on anti-viral and potentially anti-inflammatory treatments, these only ...
May 19, 2020
0
1
A team of engineers and biochemists at ANU has invented and trialled a bio-optics diagnostic device that can reveal the formation of blood clots and help doctors to identify patients at imminent risk of having a stroke or ...
Aug 29, 2018
0
1
The average human pair of lungs is permeated by a network of about 164 feet of blood vessels (roughly the width of a football field), including microscopic blood capillaries, which facilitate the diffusion of oxygen into ...
May 23, 2017
0
0
An experimental antiplatelet compound inhibited clot formation without increasing bleeding, a common and potentially dangerous side effect of current anticlotting therapies, according to new phase I research in Arteriosclerosis, ...
Apr 18, 2019
0
0
Researchers led by Professor Steve Watson and Dr. Eleyna Martin from the Institute of Cardiovascular Sciences at the University of Birmingham have delivered a breakthrough for thrombosis researchers, by producing the first ...
Oct 12, 2023
0
12